Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$378K Buy
1,312
+173
+15% +$47.9K 0.01% 433
2025
Q4
$333K Sell
1,139
-138
-11% -$38.7K 0.01% 456
2025
Q3
$376K Buy
1,277
+14
+1% +$4.14K 0.01% 416
2025
Q2
$418K Buy
1,263
+38
+3% +$12.2K 0.01% 377
2025
Q1
$403K Buy
1,225
+25
+2% +$7.53K 0.01% 381
2024
Q4
$331K Sell
1,200
-13
-1% -$4.14K 0.01% 426
2024
Q3
$420K Buy
1,213
+38
+3% +$13.1K 0.01% 378
2024
Q2
$389K Buy
1,175
+68
+6% +$23.4K 0.01% 382
2024
Q1
$402K Sell
1,107
-27
-2% -$8.89K 0.01% 390
2023
Q4
$340K Sell
1,134
-44
-4% -$12.9K 0.01% 394
2023
Q3
$337K Sell
1,178
-45
-4% -$12.8K 0.01% 384
2023
Q2
$343K Buy
1,223
+82
+7% +$21.4K 0.01% 408
2023
Q1
$292K Buy
+1,141
New +$332K 0.01% 443

Other funds holding CI

HBK Sorce Advisory's CI Position: Q1 2026 in Review

HBK Sorce Advisory increased its Cigna (CI) stake by 15% in Q1 2026, buying an estimated $47.9K and bringing the position to 1,312 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #433.

HBK Sorce Advisory first reported a position in CI in Q1 2023 and has held it in 13 quarters since. The position peaked at $420K in Q3 2024. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • HBK Sorce Advisory held 1,312 shares of Cigna worth $378K as of Q1 2026.
  • HBK Sorce Advisory bought 173 Cigna shares in Q1 2026, an estimated $47.9K.
  • Cigna made up 0.01% of HBK Sorce Advisory's portfolio in Q1 2026, its #433 holding.
  • HBK Sorce Advisory first reported a position in Cigna in Q1 2023 and has held it in 13 quarters since.
  • HBK Sorce Advisory's Cigna position peaked at $420K in Q3 2024.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.